Page last updated: 2024-09-05

lenalidomide and Benign Meningeal Neoplasms

lenalidomide has been researched along with Benign Meningeal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bohn, JP; Oberacher, H; Peschel, I; Steurer, M; Willenbacher, W1
Destian, S; Hwang, BJ; Jagannath, S; Mazumder, A; Méndez, CE; Vesole, DH1

Reviews

1 review(s) available for lenalidomide and Benign Meningeal Neoplasms

ArticleYear
Intracranial multifocal dural involvement in multiple myeloma: case report and review of the literature.
    Clinical lymphoma, myeloma & leukemia, 2010, Volume: 10, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Dura Mater; Fatal Outcome; Humans; Lenalidomide; Male; Meningeal Neoplasms; Middle Aged; Multiple Myeloma; Pyrazines; Thalidomide

2010

Other Studies

1 other study(ies) available for lenalidomide and Benign Meningeal Neoplasms

ArticleYear
Second-generation immunomodulatory drugs in leptomeningeal myeloma.
    Leukemia & lymphoma, 2019, Volume: 60, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Immunologic Factors; Lenalidomide; Male; Meningeal Neoplasms; Middle Aged; Multiple Myeloma; Thalidomide; Treatment Outcome

2019